- Digital health company Sharecare Inc SHCR reported Q4 FY22 sales of $123.30 million, up 4% Y/Y, beating the consensus of $120.25 million.
- Adjusted net loss per share was $(0.02) compared to $(0.01) a year ago.
- Jeff Arnold, chairman & CEO of Sharecare, said, “Last year, we announced plans to conduct a strategic review…We have expanded the review to include potential business combinations to complement our thriving Enterprise channel…”
- “Further, the strategic review has also affirmed the value of our Provider channel, garnering attractive valuations on a standalone basis, and we continue to actively evaluate ways to unlock that value while increasing profitability through global outsourcing and growing and retaining clients,” Arnold added.
- Adjusted EBITDA of $4.6 million declined from $5.4 million a year ago, primarily attributable to the sunsetting of the COVID-19 health security program.
- Guidance: For Q1 FY23, Sharecare expects revenues of $111-$113 million versus the consensus of $118.80 million, with adjusted EBITDA of $1-$2 million.
- For FY23, the company expects revenues of $450-$460 million, down from the consensus of $518.49 million, with adjusted EBITDA of $25-$30 million.
- Price Action: SHCR shares are down 24.43% at $1.61 on the last check Wednesday.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.